Predictive Oncology Partners with Tecan Group Ltd. for High-Throughput Drug Screening Expansion
02/10/25, 1:07 PM
Location
Industry
biotechnology
Type
partnership
Predictive Oncology Inc. announced a partnership with Switzerland-based Tecan, Ltd. to expand high-throughput drug screening to include human tumor spheroids using automated imaging and 3D analysis. This collaboration aims to utilize Predictive Oncology’s vast biobank of cryopreserved live cell tumor specimens for the production and testing of primary patient tumor spheroids.
Company Info
Location
eagan, minnesota, united states
Additional Info
Our mission at Predictive Oncology is to change the landscape of oncology drug discovery and enable the development of more effective therapies in the treatment of cancer. By harnessing the power of machine learning, scientific rigor and biologics, we can improve the probability of success and advance drug compounds with a higher degree of confidence.
We invite you to follow us to stay up-to-date about our latest developments.